Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
dOI: 10.1056/NEJMoa1411892 Kubota M, et al
The BPC-157 group showed a much higher threshold at 4 days after incision than the control group
Key Takeaways A sealed BPC-157 + TB-500 pen delivers a fixed peptide ratio per dose, eliminating reconstitution error and ratio drift across two separate vials Both peptides are unscheduled under UK drugs law but unlicensed for human use
The SURMOUNT trial program Eli Lilly ran the SURMOUNT series of phase 3 clinical trials, each testing tirzepatide in different populations and against different comparators
US$ 20.53
US$ 27.18
US$ 24.20
US$ 20.79
